Replacing even a fraction of real patients in clinical trials with virtual patients embracing digital technologies, the FDA wants to build a playbook for an in will be an innovation that will be welcomed by all. In their latest step towards silico clinical trial, which could be a game changer for medical device makers, drug companies, and clinicians.